Table 2. Predictors for non-affordability of medicines prescribed for diabetic patients.
| Characteristic | Unadjusted odds ratio | Adjusted odds ratio |
|---|---|---|
| Age (Years) | ||
| >40 | 1 | 1 |
| 30 to 40 | 1.02 (0.62–1.67) | 0.76 (0.43–1.34) |
| <30 | 1.46 (0.45–4.69) | 1.27 (0.34–4.75) |
| Gender | ||
| Male | 1 | 1 |
| Female | 1.26 (0.89–1.78) | 1.1 (0.74–1.63) |
| Setting | ||
| Rural | 1 | 1 |
| Urban | 0.92 (0.65–1.3) | 0.89 (0.6–1.32) |
| Diagnosis | ||
| Diabetes Mellitus alone | 1 | 1 |
| Diabetes Mellitus and hypertension | 1.98 (1.22–3.23) | 3.36 (1.95–5.78) |
| Diabetes Mellitus, hypertension and any other disease | 1.05 (0.52–2.12) | 2.28 (1.01–5.26) |
| Diabetes Mellitus and any other disease apart from Hypertension | 0.85 (0.48–1.49) | 1.06 (0.55–2.06) |
| Total number of drugs prescribed | ||
| <4 drugs | 1 | 1 |
| > or equal to 4 drugs | 8.31 (3.87–17.83) | 12.45 (3.9–39.7) |
| Number of injectable drugs per prescription | ||
| None | 1 | 1 |
| 1 or more injectable drugs | 14.91 (5.5–40.41) | 5.47 (1.47–20.32) |
| Class of drugs prescribed | ||
| Biguanides | 1 | 1 |
| Sulfonylureas | 0.77 (0.25–2.35) | 0.72 (0.22–2.4) |
| Biguanides and sulfonylureas | 10.15 (6.14–16.81) | 11.11 (6.64–18.61) |
| Insulin | 63.67(15.51–26.31) | 17.79 (2.95–107.28) |
| No anti-diabetic | 0.58 (0.39–0.87) | 0.38 (0.24–0.61) |